Koyfin Home > Directory > Health Care > Acceleron Pharma > Long-Term Debt

Acceleron Pharma Long-Term Debt Chart (XLRN)

Acceleron Pharma annual/quarterly Long-Term Debt from 2012 to 2013.
  • Acceleron Pharma Long-Term Debt for the quarter ending September 09, 2013 was $11m a -50.51% decrease of -6m year over year
  • Acceleron Pharma Long-Term Debt for the last 12 months ending September 09, 2013 was $11m a -50.51% decrease of -6m year over year
Other Cash Flow Metrics:
  • Acceleron Pharma Cash Flow from Operations for the quarter ending December 12, 2018 was $-29m a 19.28% decrease of -6m year over year
  • Acceleron Pharma Levered Free Cash Flow (FCF) for the quarter ending December 12, 2018 was $-41m a 62.43% decrease of -26m year over year
  • Acceleron Pharma Total Revenue for the quarter ending September 09, 2018 was $3m a -13.72% decrease of 0m year over year
View Chart On Koyfin

Quarterly XLRN Long-Term Debt Data

09/2013$11m
06/2013$13m
03/2013$15m
12/2012$17m

Annual XLRN Long-Term Debt Data

2012$17m